Ezose Sciences

Montville, United States Founded: 2009 • Age: 17 yrs Acquired By S-BIO
High-throughput glycan analysis services were provided by Ezose Sciences.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Ezose Sciences

Ezose Sciences is a company based in Montville (United States) founded in 2009 was acquired by S-BIO in August 2014. Ezose Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Montville, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    S-BIO

    (Aug 01, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ezose Sciences

Investors in Ezose Sciences

Ezose Sciences has secured backing from 1 investor. Prominent investors backing the company include S-BIO.

All
Investor Description Founded Year Domain Location
Glycan analysis services and kits are offered by S-BIO.
Locked Locked Locked
Premium access

Investor details for Ezose Sciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ezose Sciences

Investments
Premium access

Investment portfolio details for Ezose Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ezose Sciences

Premium access

Detailed financials for Ezose Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ezose Sciences Comparisons

Ezose Sciences Primary company
Description
High-throughput glycan analysis services were provided by Ez...
Location
Montville, United States
Founded Year
2009
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ezose Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ezose Sciences

Ezose Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of pharmaceuticals and vaccines for various therapeutic areas
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Yeast cells are genetically engineered to produce medicinal products.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
CRISPR-engineered cell and gene therapies are developed for research applications.
Premium access

Detailed competitors of Ezose Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ezose Sciences

Premium access

Complete news archive for Ezose Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ezose Sciences

Ezose Sciences was founded in 2009 and raised its 1st funding round 5 years after it was founded.

Ezose Sciences is headquartered in Montville, United States. It is registered at Montville, New Jersey, United States.

Ezose Sciences, a joint venture between Shionogi and Sumitomo Bakelite, provided high throughput glycan analysis services. Its platform technology GlycanMap enabled automated qualitative and quantitative mapping of glycans or the glycome using bead based capture technology, MALDI spectroscopy and proprietary bioinformatics. In Aug 2014, GlycanMap was acquired by Sumitomos US subsidiary S-bio. The rest of the business was folded into Shionogi.

Ezose Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Ezose Sciences has 1 investor. Key investors include S-BIO.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available